Nippon Life Insurance, a major life insurance company, will begin joint research with Stanford University School of Medicine in the United States to develop advanced AI (artificial intelligence) models.Targeting chronic diseases and lifestyle-related diseases, it is useful for predicting the critical transition state before the disease develops.
According to Nippon Life, the period for the joint research is from December to March 12.He will be working with Assistant Professor Bruce Lin, Professor Doff McElhinney, and Professor Carl Sylvester of Stanford University School of Medicine to develop an AI model.
As the use of AI is attracting a lot of attention in the life insurance industry, Nippon Life established an Innovation Development Office in 2018 and is working with overseas bases such as Silicon Valley in California to conduct cutting-edge AI research and apply it to its own operations. We have been applying it.
Utilizing healthcare data held by Stanford University School of Medicine, such as electronic medical records and wearable data, we will advance the prediction of chronic diseases and lifestyle-related diseases.Nippon Life expects that this joint research will contribute to the acquisition of know-how regarding AI and the development of human resources.
